306 related articles for article (PubMed ID: 20856860)
1. A new method for the characterization of strain-specific conformational stability of protease-sensitive and protease-resistant PrPSc.
Pirisinu L; Di Bari M; Marcon S; Vaccari G; D'Agostino C; Fazzi P; Esposito E; Galeno R; Langeveld J; Agrimi U; Nonno R
PLoS One; 2010 Sep; 5(9):e12723. PubMed ID: 20856860
[TBL] [Abstract][Full Text] [Related]
2. Protease-resistant prions selectively decrease Shadoo protein.
Watts JC; Stöhr J; Bhardwaj S; Wille H; Oehler A; Dearmond SJ; Giles K; Prusiner SB
PLoS Pathog; 2011 Nov; 7(11):e1002382. PubMed ID: 22163178
[TBL] [Abstract][Full Text] [Related]
3. Analyses of protease resistance and aggregation state of abnormal prion protein across the spectrum of human prions.
Saverioni D; Notari S; Capellari S; Poggiolini I; Giese A; Kretzschmar HA; Parchi P
J Biol Chem; 2013 Sep; 288(39):27972-85. PubMed ID: 23897825
[TBL] [Abstract][Full Text] [Related]
4. The Size and Stability of Infectious Prion Aggregates Fluctuate Dynamically during Cellular Uptake and Disaggregation.
Shoup D; Priola SA
Biochemistry; 2021 Feb; 60(5):398-411. PubMed ID: 33497187
[TBL] [Abstract][Full Text] [Related]
5. Small ruminant nor98 prions share biochemical features with human gerstmann-sträussler-scheinker disease and variably protease-sensitive prionopathy.
Pirisinu L; Nonno R; Esposito E; Benestad SL; Gambetti P; Agrimi U; Zou WQ
PLoS One; 2013; 8(6):e66405. PubMed ID: 23826096
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Conformational Stability of Abnormal Prion Protein Aggregates across the Spectrum of Creutzfeldt-Jakob Disease Prions.
Cescatti M; Saverioni D; Capellari S; Tagliavini F; Kitamoto T; Ironside J; Giese A; Parchi P
J Virol; 2016 Jul; 90(14):6244-6254. PubMed ID: 27122583
[TBL] [Abstract][Full Text] [Related]
7. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
Sasaki K; Minaki H; Iwaki T
J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
[TBL] [Abstract][Full Text] [Related]
8. Stability properties of PrP(Sc) from cattle with experimental transmissible spongiform encephalopathies: use of a rapid whole homogenate, protease-free assay.
Vrentas CE; Greenlee JJ; Baron T; Caramelli M; Czub S; Nicholson EM
BMC Vet Res; 2013 Aug; 9():167. PubMed ID: 23945217
[TBL] [Abstract][Full Text] [Related]
9. Conversion efficiency of bank vole prion protein in vitro is determined by residues 155 and 170, but does not correlate with the high susceptibility of bank voles to sheep scrapie in vivo.
Piening N; Nonno R; Di Bari M; Walter S; Windl O; Agrimi U; Kretzschmar HA; Bertsch U
J Biol Chem; 2006 Apr; 281(14):9373-84. PubMed ID: 16455657
[TBL] [Abstract][Full Text] [Related]
10. Sheep scrapie susceptibility-linked polymorphisms do not modulate the initial binding of cellular to disease-associated prion protein prior to conversion.
Rigter A; Bossers A
J Gen Virol; 2005 Sep; 86(Pt 9):2627-2634. PubMed ID: 16099922
[TBL] [Abstract][Full Text] [Related]
11. Species barrier in prion diseases: a kinetic interpretation based on the conformational adaptation of the prion protein.
Kellershohn N; Laurent M
Biochem J; 1998 Sep; 334 ( Pt 3)(Pt 3):539-45. PubMed ID: 9729459
[TBL] [Abstract][Full Text] [Related]
12. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
[TBL] [Abstract][Full Text] [Related]
13. Acidic pH and detergents enhance in vitro conversion of human brain PrPC to a PrPSc-like form.
Zou WQ; Cashman NR
J Biol Chem; 2002 Nov; 277(46):43942-7. PubMed ID: 12161431
[TBL] [Abstract][Full Text] [Related]
14. Differential solubility of prions is associated in manifold phenotypes.
Kuczius T; Karch H; Groschup MH
Mol Cell Neurosci; 2009 Nov; 42(3):226-33. PubMed ID: 19607920
[TBL] [Abstract][Full Text] [Related]
15. Acute formation of protease-resistant prion protein does not always lead to persistent scrapie infection in vitro.
Vorberg I; Raines A; Priola SA
J Biol Chem; 2004 Jul; 279(28):29218-25. PubMed ID: 15133048
[TBL] [Abstract][Full Text] [Related]
16. Reversibility of scrapie-associated prion protein aggregation.
Callahan MA; Xiong L; Caughey B
J Biol Chem; 2001 Jul; 276(30):28022-8. PubMed ID: 11375994
[TBL] [Abstract][Full Text] [Related]
17. Biochemistry and structure of PrP(C) and PrP(Sc).
Riesner D
Br Med Bull; 2003; 66():21-33. PubMed ID: 14522846
[TBL] [Abstract][Full Text] [Related]
18. Isolation of a Defective Prion Mutant from Natural Scrapie.
Vanni I; Migliore S; Cosseddu GM; Di Bari MA; Pirisinu L; D'Agostino C; Riccardi G; Agrimi U; Nonno R
PLoS Pathog; 2016 Nov; 12(11):e1006016. PubMed ID: 27880822
[TBL] [Abstract][Full Text] [Related]
19. Uptake and degradation of protease-sensitive and -resistant forms of abnormal human prion protein aggregates by human astrocytes.
Choi YP; Head MW; Ironside JW; Priola SA
Am J Pathol; 2014 Dec; 184(12):3299-307. PubMed ID: 25280631
[TBL] [Abstract][Full Text] [Related]
20. Tracing conformational transition of abnormal prion proteins during interspecies transmission by using novel antibodies.
Ushiki-Kaku Y; Endo R; Iwamaru Y; Shimizu Y; Imamura M; Masujin K; Yamamoto T; Hattori S; Itohara S; Irie S; Yokoyama T
J Biol Chem; 2010 Apr; 285(16):11931-6. PubMed ID: 20177064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
